Loading
Life sciences · Journal article
International Journal of Advanced Research · September 22, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background:Lung cancer is one of the most common causes of cancer associated mortality worldwide and limits of conventional therapy has resulted in interest in traditional medicinal formulations. ShadgunabalijaritaRasa Sindooris one of the classical KupipakwaRasayanapreparations used traditionally for different diseases but its pharmacological standardisation and anticancer potential needs scientific substantiation.Materials and Methods: The formulation was manufactured by classical processes of Rasashastraafter due purification and pharmaceutical processing. The final product was investigated for pharmaceutico-analytical parameters including instrumental characterisation. Cytotoxic activity against A-549 cells was tested by MTT assay. Cell viability and IC-50 values were established.